New clues about vitamin D functions in the nervous system

被引:682
作者
Garcion, E
Wion-Barbot, N
Montero-Menei, CN
Berger, F
Wion, D
机构
[1] INSERM, ERITM 0104, F-49100 Angers, France
[2] Endocrinol Grp, F-38000 Grenoble, France
[3] CHU Michallon, INSERM, U318, F-38043 Grenoble, France
关键词
D O I
10.1016/S1043-2760(01)00547-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Accumulating data have provided evidence that 1alpha,25 dihydroxyvitamin D-3 [1,25-(OH)(2)D-3] is involved in brain function. Thus,the nuclear receptor for 1,25-(OH)(2)D-3 has been localized in neurons and glial cells. Genes encoding the enzymes involved in the metabolism of this hormone are also expressed in brain cells. The reported biological effects of 1,25-(OH)(2)D-3 in the nervous system include the biosynthesis of neurotrophic factors and at least one enzyme involved in neurotransmitter synthesis. 1,25-(OH)(2)D-3 can also inhibit the synthesis of inducible nitric oxide synthase and increase glutathione levels, suggesting a role for the hormone in brain detoxification pathways. Neuroprotective and immunomodulatory effects of this hormone have been described in several. experimental models, indicating the potential value of 1,25-(OH)(2)D-3 pharmacological analogs in neurodegenerative and neuroimmune diseases. In addition, 1,25-(OH)(2)D-3 induces glioma cell death, making the hormone of potential interest in the management of brain tumors. These results reveal previously unsuspected roles for 1,25-(OH)(2)D-3 in brain function and suggest possible areas of future research.
引用
收藏
页码:100 / 105
页数:6
相关论文
共 90 条
  • [1] DIFFERENTIATION OF MOUSE MYELOID-LEUKEMIA CELLS INDUCED BY 1-ALPHA,25-DIHYDROXYVITAMIN-D3
    ABE, E
    MIYAURA, C
    SAKAGAMI, H
    TAKEDA, M
    KONNO, K
    YAMAZAKI, T
    YOSHIKI, S
    SUDA, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (08): : 4990 - 4994
  • [2] Alvarez-Dolado M, 1999, J NEUROSCI RES, V58, P293, DOI 10.1002/(SICI)1097-4547(19991015)58:2<293::AID-JNR9>3.0.CO
  • [3] 2-H
  • [4] Baas D, 2000, GLIA, V31, P59, DOI 10.1002/(SICI)1098-1136(200007)31:1<59::AID-GLIA60>3.0.CO
  • [5] 2-Y
  • [6] BACHET P, 2000, NEUROIMMUNE INTERACT, P193
  • [7] CHRONIC VITAMIN-D DEFICIENCY IN THE WEANLING RAT ALTERS CATECHOLAMINE METABOLISM IN THE CORTEX
    BAKSI, SN
    HUGHES, MJ
    [J]. BRAIN RESEARCH, 1982, 242 (02) : 387 - 390
  • [8] 25-HYDROXYVITAMIN-D, 24, 25-DIHYDROXYVITAMIN-D AND 1,25-DIHYDROXYVITAMIN-D IN HUMAN CEREBROSPINAL-FLUID
    BALABANOVA, S
    RICHTER, HP
    ANTONIADIS, G
    HOMOKI, J
    KREMMER, N
    HANLE, J
    TELLER, WM
    [J]. KLINISCHE WOCHENSCHRIFT, 1984, 62 (22): : 1086 - 1090
  • [9] Baudet C, 1996, J NEUROSCI RES, V46, P540, DOI 10.1002/(SICI)1097-4547(19961201)46:5<540::AID-JNR3>3.0.CO
  • [10] 2-J